Month: November 2021

A new stent improves the treatment of coronary heart disease in people with diabetes

Its greater effectiveness has been verified in a study coordinated by the Bellvitge Hospital and IDIBELL. The new device reduces the number of serious complications by 35% one year after the intervention. The study was published in the world’s leading cardiovascular journal.

The study of genetic variants for the early detection of colorectal cancer: current state and future perspectives

An IDIBELL and ICO study determines that the set of genetic variants has an important role in the evolution of colorectal cancer. However, it is still too soon to use them as the single tool for screening and early detection of colorectal cancer.

Described new predictors of mortality in severe pulmonary embolism

A study carried out by researchers from IDIBELL and the Bellvitge University Hospital has described new predictors of mortality in the endovascular treatment of severe pulmonary embolism.

Dr. Joan Fabregat receives the Virgili Award from the Catalan Society of Surgery

Dr. Joan Fabregat Prous, a principal investigator of the IDIBELL hepato-biliary-pancreatic pathology research group and head of the section of the General and Digestive Surgery Service of the Bellvitge University Hospital, received the “Pere Virgili Award” on October 14th. The event took place at the Royal Academy of Medicine of Catalonia.

Scroll to Top